Showing items 1 - 20 of 36

Your selections:

96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial

Acute experimental pain responses in methadone- and buprenorphine/naloxone-maintained patients administered additional opioid or gabapentin: a double-blind crossover pilot study

An evaluation of the prescription of opioids for chronic nonmalignant pain by Australian general practitioners

An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy

Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations

Assessing the validity of the Australian treatment outcomes profile for telephone administration in drug health treatment populations

Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: results from a placebo-controlled randomised trial

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic

Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series

Correlates of pain in an in-treatment sample of opioid-dependent people

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions

Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: the Opioid-Related Behaviours In Treatment (ORBIT) scale

Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial

Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field

Health and Social Characteristics of Clients Reporting Amphetamine Type Substance Use at Entry to Public Alcohol and Other Drug Services in New South Wales, Australia, 2016–2019

Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial

Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder

Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial

Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial

  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit